ziprasidone has been researched along with Mental Disorders in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (75.00) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siegfried, N; Stein, DJ; Temmingh, HS; Williams, T | 1 |
| Biesdorf, C; Diniz, A; Martins, FS; Sy, SKB | 1 |
| Shrestha, R | 1 |
| Connolly, JG; Schneeweiss, MC; Toomey, TJ | 1 |
| Al-Jadiri, A; Azzo, S; Carbon, M; Correll, CU; Kane, JM; Kapoor, S; Saito, E; Sarkaria, T; Sheridan, E | 1 |
| Gründer, G; Hiemke, C; Kircher, T; Leube, D; Saur, R; Schlotterbeck, P; Vehren, T | 1 |
| Price, LH | 1 |
| DeLorenze, G; L'Italien, G; McQuade, R; Newcomer, J; Oliveria, SA; Quesenberry, CP; Tsai, AL; Willey, VJ; Yood, MU | 1 |
| Helm, ME; Henderson, C; Martin, BC; Pathak, P; West, D | 1 |
| Chowdhury, WA; Firoz, AH; Mamun, AA; Rahman, AH | 1 |
| Cohen, S; Fitzgerald, B; Khan, A; Khan, S; Okos, A | 1 |
| Bailey, RK | 1 |
| Ramos, AE; Sanberg, PR; Shytle, RD; Silver, AA | 1 |
| Findling, RL; McNamara, NK | 1 |
| Citrome, L; Volavka, J | 1 |
| Bobes, J; Cañas, F; Mackell, J; Rejas, J | 1 |
| Baldassano, C; Ballas, C; Ballas, P; O'Reardon, J; Yang, C | 1 |
| Correll, CU | 1 |
| de Oliveira Lança, G; Hara, C; Kascher, GG; Magalhães Scoralick, F; Ramos, MG; Rocha, FL; Santos, MA | 1 |
| Delgado, SV; Saldaña, SN | 1 |
| Lebovitz, HE; Loebel, AD; Newcomer, JW; Weiden, PJ; Yang, R | 1 |
| Wooten, J | 1 |
| Barzman, DH; DelBello, MP; Forrester, JJ; Keck, PE; Strakowski, SM | 1 |
| Eidelman, P; Nierenberg, AA; Smoller, JW; Tilley, CA; Wu, YP | 1 |
7 review(s) available for ziprasidone and Mental Disorders
| Article | Year |
|---|---|
Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Diagnosis, Dual (Psychiatry); Humans; Mental Disorders; Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Substance-Related Disorders; Thiazoles | 2018 |
Brief report on Ziprasidone.
Topics: Antipsychotic Agents; Humans; Mental Disorders; Piperazines; Thiazoles | 2002 |
Atypical psychotropic medications and their adverse effects: a review for the African-American primary care physician.
Topics: Adult; Aged; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Black or African American; Bone Marrow Diseases; Child; Dibenzothiazepines; Endocrine System Diseases; Humans; Mental Disorders; Nervous System Diseases; Olanzapine; Piperazines; Pirenzepine; Primary Health Care; Quetiapine Fumarate; Risperidone; Thiazoles | 2003 |
Atypical antipsychotics in the treatment of children and adolescents: clinical applications.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Child; Child Development Disorders, Pervasive; Clozapine; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Tic Disorders | 2004 |
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain | 2004 |
Ziprasidone: a novel psychotropic with unique properties.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Humans; Mental Disorders; Piperazines; Schizophrenia; Thiazoles | 2004 |
Metabolic effects of the atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dyslipidemias; Glucose Metabolism Disorders; Humans; Insulin Resistance; Mental Disorders; Obesity; Olanzapine; Phenothiazines; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2007 |
4 trial(s) available for ziprasidone and Mental Disorders
| Article | Year |
|---|---|
Weight, lipids, glucose, and behavioral measures with ziprasidone treatment in a population with mental retardation.
Topics: Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Intellectual Disability; Lipids; Male; Mental Disorders; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome; Triglycerides | 2003 |
Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dyskinesia, Drug-Induced; Follow-Up Studies; Haloperidol; Hospitalization; Humans; Mental Disorders; Models, Econometric; Olanzapine; Outpatients; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Sensitivity and Specificity; Spain; Survival Analysis; Thiazoles; Treatment Outcome; Weight Gain | 2004 |
An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Disorders of Excessive Somnolence; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease, Secondary; Piperazines; Thiazoles | 2006 |
Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone.
Topics: Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Brief Psychiatric Rating Scale; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Lipids; Male; Mental Disorders; Olanzapine; Piperazines; Retrospective Studies; Single-Blind Method; Thiazoles; Time Factors | 2008 |
13 other study(ies) available for ziprasidone and Mental Disorders
| Article | Year |
|---|---|
Physiologically-based pharmacokinetics of ziprasidone in pregnant women.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Area Under Curve; Caco-2 Cells; Child; Computer Simulation; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Healthy Volunteers; Humans; Mental Disorders; Models, Biological; Piperazines; Pregnancy; Pregnancy Complications; Thiazoles | 2019 |
Clinical lycanthropy: delusional misidentification of the "self".
Topics: Delusions; Dopamine Antagonists; Humans; Male; Mental Disorders; Piperazines; Self Concept; Thiazoles; Young Adult | 2014 |
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles | 2015 |
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Multivariate Analysis; New York; Olanzapine; Parkinson Disease, Secondary; Piperazines; Prospective Studies; Quetiapine Fumarate; Regression Analysis; Risperidone; Thiazoles | 2015 |
Low concentration of ziprasidone in human milk: a case report.
Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Female; Humans; Mental Disorders; Milk, Human; Piperazines; Thiazoles; Time Factors; Young Adult | 2009 |
Atypical antipsychotic drugs and the risk of sudden cardiac death.
Topics: Antipsychotic Agents; Aripiprazole; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Humans; Mental Disorders; Piperazines; Quinolones; Risk; Thiazoles | 2009 |
The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Cohort Studies; Diabetes Mellitus; Female; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Piperazines; Quinolones; Retrospective Studies; Thiazoles; United States | 2009 |
Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Drug Utilization; Evidence-Based Medicine; Female; Humans; Infant; Insurance Claim Review; Male; Medicaid; Mental Disorders; Off-Label Use; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; United States; United States Food and Drug Administration | 2010 |
Ziprasidone-induced oculogyric crisis.
Topics: Antipsychotic Agents; Child; Dystonia; Humans; Male; Mental Disorders; Ocular Motility Disorders; Piperazines; Thiazoles | 2003 |
Real-life switching strategies with second-generation antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dibenzothiazepines; Drug Administration Schedule; Drug Resistance; Humans; Mental Disorders; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Selection Bias; Thiazoles; Treatment Outcome | 2006 |
Ziprasidone-associated galactorrhea in an adolescent female.
Topics: Adolescent; Antipsychotic Agents; Female; Galactorrhea; Humans; Hyperprolactinemia; Mental Disorders; Piperazines; Thiazoles | 2007 |
A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.
Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Child; Child, Preschool; Electrocardiography; Female; Hospitals, Pediatric; Humans; Injections, Intramuscular; Male; Mental Disorders; Piperazines; Psychiatric Department, Hospital; Psychiatric Status Rating Scales; Psychomotor Agitation; Regression Analysis; Retrospective Studies; Sex Factors; Sleep Stages; Thiazoles; Treatment Outcome | 2007 |
Critical thinking about adverse drug effects: lessons from the psychology of risk and medical decision-making for clinical psychopharmacology.
Topics: Advertising; Benzodiazepines; Conflict of Interest; Decision Support Techniques; Drug Industry; Ethics, Medical; Evidence-Based Medicine; Humans; Marketing; Mental Disorders; Olanzapine; Piperazines; Propaganda; Psychiatry; Psychotropic Drugs; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Thiazoles; United States | 2008 |